NCT03384472 is a clinical trial in Parasitology, sponsored by University of Oxford.

Who is sponsoring NCT03384472?

NCT03384472 is sponsored by University of Oxford.

What condition does NCT03384472 study?

NCT03384472 studies Parasitology, Entomology, Malaria.

Is NCT03384472 still recruiting?

NCT03384472 is currently completed. Last updated 24 May 2022.

Last reviewed 2022-05-24 · How we verify

NCT03384472

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malaria Genetic Surveillance in Cambodia

Completed Last updated 24 May 2022

What this trial tests

trial in Parasitology in 185 participants. Completed in 1 February 2017.

Timeline

1 June 2016

Primary endpoint
1 February 2017

1 February 2017

Quick facts

Lead sponsor	University of Oxford
Status	Completed
Study type	OBSERVATIONAL
Enrollment	185
Start date	1 June 2016
Primary completion	1 February 2017
Estimated completion	1 February 2017

Conditions studied

Parasitology — all drugs for Parasitology →
Entomology — all drugs for Entomology →
Malaria — all drugs for Malaria →

Sponsor

University of Oxford

Who can join

6 Months and older, any sex, with Parasitology or Entomology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to determine the prevalence and geographical distribution of antimalarial drug resistance-linked genetic mutations in clinical P. falciparum infections in Cambodia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03384472 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 24 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03384472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing